The current Coronavirus Disease-2019 (COVID-19) pandemic needs no introduction To save lives and revive the global economy, the need of the hour is a safe and effective vaccine which does not enhance viral disease Scientists are using traditional, modern, and novel platforms to develop their vaccine candidates Each platform has its pros and cons Novel platforms will shorten our response time against biohazards of the future Vaccine development is being rushed and we are optimistic that we will have a vaccine as early as mid-2021 World health organisation, governments, pharma giants, researchers, private companies, and philanthropists have joined their hands to fund the vaccine hunt and to ensure an equitable Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccine access to people all across the world Our review highlights potential problems in vaccine development, plans for vaccine allocation, and hurdles for vaccine uptake It also throws light on vaccine delays due to a lack of confidence in the safety and effectivity of the vaccine, along with difficulties to access a shot
Development across the world on vaccines for COVID-19: A primer for primary care physicians